Search Within

Angela Marchetti

Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
Groups
  1. Department of Pathology and Laboratory Medicine (6)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Tow Center for Developmental Oncology (TCDO) (5)
  5. Center for Hematologic Malignancies (3)
  6. Pediatric Leukemia (3)

More Groups

People
  1. Marc Ladanyi (5)
  2. Laetitia Borsu Valente (4)
  3. Agnes Viale (3)
  4. Donavan Cheng (3)
  5. Jacklyn Casanova (3)
  6. Snjezana Dogan (3)

More People

Years
  1. 2015 (2)
  2. 2014 (2)
  3. 2013 (1)
  4. 2012 (1)
Publications
  1. Journal of Molecular Diagnostics (2)
  2. Archives of Pathology & Laboratory Medicine (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. Nature Genetics (1)
Publishers
  1. Elsevier Science, Inc. (2)
  2. American Association for Cancer Research (1)
  3. American Society of Clinical Oncology (1)
  4. College of American Pathologists (1)
  5. Nature Publishing Group (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Depletion of core needle biopsy cellularity and DNA content as a result of vigorous touch preparations
    Journal Article

    Rekhtman, N.; Kazi, S.; Yao, J.; Dogan, S.; Yannes, A.; Lin, O.; Silk, M.; Silk, T.; Durack, J. C.
    Archives of Pathology & Laboratory Medicine (2015)

    Fulltext@MSK | Save
  • Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
    Journal Article

    Cheng, D. T.; Mitchell, T. N.; Zehir, A.; Shah, R. H.; Benayed, R.; Syed, A.; Chandramohan, R.; Liu, Z. Y.; Won, H. H.; Scott, S. N.; more...
    Journal of Molecular Diagnostics (2015)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Systematic evaluation of KRAS mutation detection using an AmpliSeq custom panel and ion torrent sequencing in 113 KRAS-mutated lung cancers
    Meeting Abstract

    Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; Lailler, N.; Cheng, D.; Viale, A.; Yu, H.; Riely, G.; more...
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save
  • Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways
    Journal Article

    Shukla, N.; Ameur, N.; Yilmaz, I.; Nafa, K.; Lau, C. Y.; Marchetti, A.; Borsu, L.; Barr, F. G.; Ladanyi, M.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save